Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine
- PMID: 6022611
Item in Clipboard
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine
J Natl Cancer Inst.
1967 Mar.
No abstract available
Similar articles
-
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil.J Natl Cancer Inst. 1967 Mar;38(3):401-5. J Natl Cancer Inst. 1967. PMID: 6022612 No abstract available.
-
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells of mice to vinblastine administered in vivo.J Natl Cancer Inst. 1966 Jan;36(1):21-7. J Natl Cancer Inst. 1966. PMID: 5901524 No abstract available.
-
The action of chemotherapeutic agents at the cellular level and the effects of these agents on hematopoietic and lymphomatous tissue.Proc Can Cancer Conf. 1967;7:53-64. Proc Can Cancer Conf. 1967. PMID: 6047866 No abstract available.
-
Cytotoxic drugs and the granulopoietic system.Recent Results Cancer Res. 1982;81:1-222. doi: 10.1007/978-3-642-81690-1. Recent Results Cancer Res. 1982. PMID: 6173905 Review. No abstract available.
-
[Side effect of antineoplastic agents and its prevention].Naika. 1971 Oct;28(4):685-9. Naika. 1971. PMID: 4943167 Review. Japanese. No abstract available.
Cited by
-
The effect of cytotoxic agents on the passive transfer of cell-mediated immunity.J Exp Med. 1969 Jul 1;130(1):17-30. doi: 10.1084/jem.130.1.17. J Exp Med. 1969. PMID: 4978230 Free PMC article.
-
Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.Can Med Assoc J. 1968 Mar 16;98(11):532-8. Can Med Assoc J. 1968. PMID: 5643297 Free PMC article. No abstract available.
-
An assessment of massive-dose chemotherapy of malignant disease.Can Med Assoc J. 1971 Jan 9;104(1):31-6. Can Med Assoc J. 1971. PMID: 4322068 Free PMC article. Review. No abstract available.